New strategy of reprogramming regulatory T cells may improve cancer therapies

15:00 EDT 15 May 2019 | ecancermedicalscience

While therapies that harness the power of the immune system against cancer have made remarkable progress against certain types of tumours, they still remain ineffective in most cancer patients. A new study has described a method of reprogramming the...

More From BioPortfolio on "New strategy of reprogramming regulatory T cells may improve cancer therapies"